{
    "eid": "2-s2.0-85140595724",
    "title": "Investigation of Genes and Proteins Expression Associating Serotonin Signaling Pathway in Lung and Pulmonary Artery Tissues of Dogs with Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease: The Preliminary Study",
    "cover-date": "2022-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        }
    ],
    "keywords": [
        "canine",
        "degenerative mitral valve disease",
        "gene",
        "lung",
        "protein",
        "pulmonary artery",
        "pulmonary hypertension",
        "serotonin"
    ],
    "authors": [
        "Nattawan Tangmahakul",
        "Siriwan Sakarin",
        "Somporn Techangamsuwan",
        "Anudep Rungsipipat",
        "Sirilak Disatian Surachetpong"
    ],
    "citedby-count": 0,
    "ref-count": 83,
    "ref-list": [
        "ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs",
        "Pulmonary hypertension and cardiovascular sequelae in 54 dogs",
        "Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure",
        "Pulmonary hypertension in mitral regurgitation",
        "Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease",
        "Comparison of primary mitral valve disease in German Shepherd dogs and in small breeds",
        "Serum cardiac troponin I concentration in dogs with precapillary and postcapillary pulmonary hypertension",
        "Detection of congestive heart failure in dogs by Doppler echocardiography",
        "Doppler echocardiography\u2013derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001\u20132005)",
        "Serotonin 2B receptor is required for heart development",
        "Coagulation and anticoagulation in pulmonary arterial hypertension",
        "Serotonin transporter and serotonin receptors",
        "Identification of primary lysosomes in human megakaryocytes and platelets",
        "Ultrastructural localization of 5-hydroxy-tryptamine in blood platelets",
        "The dense bodies of human platelets: Inherent electron opacity of the serotonin storage particles",
        "Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension",
        "The fate of circulating amines within the pulmonary circulation",
        "A new role for an old molecule: Serotonin as a mitogen",
        "Serotonin signaling is a very early step in patterning of the left-right axis in chick and frog embryos",
        "Neurotransmitters as growth regulatory signals: Role of receptors and second messengers",
        "Ablation of serotonin 5-HT2B receptors in mice leads to abnormal cardiac structure and function",
        "A novel role for serotonin in heart",
        "Aminorex, dexfenfluramine, and primary pulmonary hypertension",
        "Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension",
        "Serotonin passes through myoendothelial gap junctions to promote pulmonary arterial smooth muscle cell differentiation",
        "H2O2signals 5-HT-induced ERK MAP kinase activation and mitogenesis of smooth muscle cells",
        "Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion",
        "Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin",
        "Activation of GATA-4 by serotonin in pulmonary artery smooth muscle cells",
        "Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn",
        "Serotonin and pulmonary hypertension\u2014From bench to bedside?",
        "The Expression of Proteins Related to Serotonin Pathway in Pulmonary Arteries of Dogs Affected With Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease",
        "ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs",
        "Clinical pharmacology of tramadol and tapentadol, and their therapeutic efficacy in different models of acute and chronic pain in dogs and cats",
        "Selection of the appropriate reference genes for relative quantitative reverse transcription polymerase chain reaction (qRT-PCR) in canine pulmonary arteries",
        "Development and application of multiple internal reference (housekeeper) gene assays for accurate normalisation of canine gene expression studies",
        "Analyzing real-time PCR data by the comparative C(T) method",
        "Development and evaluation of canine reference genes for accurate quantification of gene expression",
        "Dystrophin deficiency impairs vascular structure and function in the canine model of Duchenne muscular dystrophy",
        "The Serotonin Pathway in Pulmonary Hypertension",
        "Pulmonary hypertension: Therapeutic targets within the serotonin system",
        "Pulmonary hypertension and the serotonin hypothesis: Where are we now?",
        "Tryptophan hydroxylase 1 inhibition impacts pulmonary vascular remodeling in two rat models of pulmonary hypertension",
        "Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension",
        "Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model",
        "Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice",
        "The right heart and pulmonary circulation (III). The pulmonary circulation in heart failure",
        "4-Chloro-DL-phenylalanine protects against monocrotaline-induced pulmonary vascular remodeling and lung inflammation",
        "Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension",
        "Serotonin biosynthesis as a predictive marker of serotonin pharmacodynamics and disease-induced dysregulation",
        "Peripheral Serotonin Synthesis as a New Drug Target",
        "Gene Therapy by Targeted Adenovirus-mediated Knockdown of Pulmonary Endothelial Tph1 Attenuates Hypoxia-induced Pulmonary Hypertension",
        "5-hydroxytryptamine in the cardiovascular system: Focus on the serotonin transporter (SERT)",
        "Fluoxetine attenuates chronic methamphetamine-induced pulmonary arterial remodelling: Possible involvement of serotonin transporter and serotonin 1B receptor",
        "Involvement of serotonin mechanism in methamphetamine-induced chronic pulmonary toxicity in rats",
        "The serotonin hypothesis in pulmonary hypertension revisited: Targets for novel therapies (2017 Grover Conference Series)",
        "Proliferation and signaling in fibroblasts: Role of 5-hydroxytryptamine2A receptor and transporter",
        "Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: Role of 5-HT2A receptors, caveolin-1, and KV1.5 channel internalization",
        "Serotonin receptors 5-HTR2A and 5-HTR2B are involved in cigarette smoke-induced airway inflammation, mucus hypersecretion and airway remodeling in mice",
        "Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice",
        "Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: A rationale for therapeutic intervention",
        "Serotonin aggravates exercise-induced cardiac ischemia in the dog: Effect of serotonin receptor antagonists",
        "Expression of the serotonin 1b receptor in experimental pulmonary hypertension",
        "Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension: Converging evidence using 5-HT1B-receptor knockout mice and the 5-HT1B/1D-receptor antagonist GR127935",
        "Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension",
        "Evaluation of the effects of RP5063, a novel, multimodal, serotonin receptor modulator, as single-agent therapy and co-administrated with sildenafil, bosentan, and treprostinil in a monocrotaline-induced pulmonary arterial hypertension rat model",
        "RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia\u2013induced pulmonary arterial hypertension in rats",
        "RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats",
        "Serotonin inhibits apoptosis of pulmonary artery smooth muscle cells through 5-HT2A receptors involved in the pulmonary artery remodeling of pulmonary artery hypertension",
        "Hypoxia-Induced Epithelial-To-Mesenchymal Transition Mediates Fibroblast Abnormalities via ERK Activation in Cutaneous Wound Healing",
        "Protein kinase C\u03b1 stimulates hypoxia-induced pulmonary artery smooth muscle cell proliferation in rats through activating the extracellular signal-regulated kinase 1/2 pathway",
        "Hypoxia Enhances Proliferation of Human Adipose-Derived Stem Cells via HIF-1\u03b1 Activation",
        "The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation",
        "Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension",
        "Long-term use of sildenafil in the therapeutic management of heart failure",
        "Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension",
        "Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: A long-term cardiopulmonary exercise testing placebo-controlled study",
        "Effects of 5\u2032-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: A double-blind, placebo-controlled clinical trial",
        "Sildenafil in heart failure with reactive pulmonary hypertension (Sildenafil HF) clinical trial (rationale and design)",
        "Acute resolution of pulmonary alveolar infiltrates in 10 dogs with pulmonary hypertension treated with sildenafil citrate: 2005\u20132014",
        "Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension",
        "Increased mitral valve regurgitation and myocardial hypertrophy in two dogs with long-term pimobendan therapy"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn University"
    ]
}